CellaVision AB (publ)

SSE:CEVI.ST

257 (SEK) • At close February 20, 2024
Bedrijfsnaam CellaVision AB (publ)
Symbool CEVI.ST
Munteenheid SEK
Prijs 257
Beurswaarde 6,129,835,500
Dividendpercentage 0.98%
52-weken bereik 120 - 275
Industrie Medical Devices
Sector Healthcare
CEO Mr. Simon Ostergaard
Website https://www.cellavision.com

An error occurred while fetching data.

Over CellaVision AB (publ)

CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears

Vergelijkbare Aandelen

BICO Group AB (publ) logo

BICO Group AB (publ)

BICO.ST

45.4 SEK

Surgical Science Sweden AB (publ) logo

Surgical Science Sweden AB (publ)

SUS.ST

179.1 SEK

Xvivo Perfusion AB (publ) logo

Xvivo Perfusion AB (publ)

XVIVO.ST

282 SEK

BioArctic AB (publ) logo

BioArctic AB (publ)

BIOA-B.ST

227.8 SEK

BioGaia AB (publ) logo

BioGaia AB (publ)

BIOG-B.ST

124.4 SEK

Synsam AB (publ) logo

Synsam AB (publ)

SYNSAM.ST

45.15 SEK

Camurus AB (publ) logo

Camurus AB (publ)

CAMX.ST

440 SEK

Calliditas Therapeutics AB (publ) logo

Calliditas Therapeutics AB (publ)

CALTX.ST

107.8 SEK

Ambea AB (publ) logo

Ambea AB (publ)

AMBEA.ST

57.2 SEK

Attendo AB (publ) logo

Attendo AB (publ)

ATT.ST

37.8 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)